Oncolytics Biotech Inc.
ONCY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $16 | $35 | $12 | $41 |
| Short-Term Investments | $0 | $0 | $20 | $0 |
| Receivables | $0 | $0 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $3 | $3 | $3 |
| Total Curr. Assets | $19 | $38 | $36 | $45 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1 | $0 |
| Total NC Assets | $1 | $1 | $2 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $20 | $39 | $37 | $46 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $3 | $1 | $2 |
| Total Curr. Liab. | $7 | $4 | $4 | $3 |
| LT Debt | $1 | $0 | $0 | $0 |
| Deferred Rev, NC | $7 | $7 | $7 | $7 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $8 | $7 | $7 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $0 | $1 |
| Total Liabilities | $14 | $11 | $11 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $438 | $431 | $404 | $391 |
| Retained Earnings | -$478 | -$446 | -$418 | -$393 |
| AOCI | $1 | $1 | $1 | $0 |
| Other Equity | $45 | $42 | $40 | $38 |
| Total Equity | $6 | $28 | $27 | $36 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $20 | $39 | $37 | $46 |
| Net Debt | -$15 | -$34 | -$11 | -$41 |